Table of Content

1 RNA-based Biopharmaceuticals Market Overview
1.1 RNA-based Biopharmaceuticals Product Scope
1.2 RNA-based Biopharmaceuticals Segment by Type
1.2.1 Global RNA-based Biopharmaceuticals Sales by Type (2016 & 2021 & 2027)
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 RNA-based Biopharmaceuticals Segment by Application
1.3.1 Global RNA-based Biopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 RNA-based Biopharmaceuticals Market Estimates and Forecasts (2016-2027)
1.4.1 Global RNA-based Biopharmaceuticals Market Size in Value Growth Rate (2016-2027)
1.4.2 Global RNA-based Biopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global RNA-based Biopharmaceuticals Price Trends (2016-2027)

2 RNA-based Biopharmaceuticals Estimates and Forecasts by Region
2.1 Global RNA-based Biopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
2.2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2016-2021)
2.3 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
2.4.2 Europe RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
2.4.3 China RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
2.4.4 Japan RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
2.4.5 Southeast Asia RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)
2.4.6 India RNA-based Biopharmaceuticals Estimates and Projections (2016-2027)

3 Global RNA-based Biopharmaceuticals Competition Landscape by Players
3.1 Global Top RNA-based Biopharmaceuticals Players by Sales (2016-2021)
3.2 Global Top RNA-based Biopharmaceuticals Players by Revenue (2016-2021)
3.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2020)
3.4 Global RNA-based Biopharmaceuticals Average Price by Company (2016-2021)
3.5 Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global RNA-based Biopharmaceuticals Market Size by Type
4.1 Global RNA-based Biopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 Global RNA-based Biopharmaceuticals Price by Type (2016-2021)
4.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Type (2022-2027)

5 Global RNA-based Biopharmaceuticals Market Size by Application
5.1 Global RNA-based Biopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 Global RNA-based Biopharmaceuticals Price by Application (2016-2021)
5.2 Global RNA-based Biopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2022-2027)

6 North America RNA-based Biopharmaceuticals Market Facts & Figures
6.1 North America RNA-based Biopharmaceuticals Sales by Company
6.1.1 North America RNA-based Biopharmaceuticals Sales by Company (2016-2021)
6.1.2 North America RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
6.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type
6.2.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
6.2.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
6.3 North America RNA-based Biopharmaceuticals Sales Breakdown by Application
6.3.1 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
6.3.2 North America RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe RNA-based Biopharmaceuticals Market Facts & Figures
7.1 Europe RNA-based Biopharmaceuticals Sales by Company
7.1.1 Europe RNA-based Biopharmaceuticals Sales by Company (2016-2021)
7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
7.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type
7.2.1 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
7.2.2 Europe RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
7.3 Europe RNA-based Biopharmaceuticals Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China RNA-based Biopharmaceuticals Market Facts & Figures
8.1 China RNA-based Biopharmaceuticals Sales by Company
8.1.1 China RNA-based Biopharmaceuticals Sales by Company (2016-2021)
8.1.2 China RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
8.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type
8.2.1 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
8.2.2 China RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
8.3 China RNA-based Biopharmaceuticals Sales Breakdown by Application
8.3.1 China 168 Sales Breakdown by Application (2016-2021)
8.3.2 China 168 Sales Breakdown by Application (2022-2027)

9 Japan RNA-based Biopharmaceuticals Market Facts & Figures
9.1 Japan RNA-based Biopharmaceuticals Sales by Company
9.1.1 Japan RNA-based Biopharmaceuticals Sales by Company (2016-2021)
9.1.2 Japan RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
9.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type
9.2.1 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
9.2.2 Japan RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
9.3 Japan RNA-based Biopharmaceuticals Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia RNA-based Biopharmaceuticals Market Facts & Figures
10.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company
10.1.1 Southeast Asia RNA-based Biopharmaceuticals Sales by Company (2016-2021)
10.1.2 Southeast Asia RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
10.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type
10.2.1 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia RNA-based Biopharmaceuticals Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India RNA-based Biopharmaceuticals Market Facts & Figures
11.1 India RNA-based Biopharmaceuticals Sales by Company
11.1.1 India RNA-based Biopharmaceuticals Sales by Company (2016-2021)
11.1.2 India RNA-based Biopharmaceuticals Revenue by Company (2016-2021)
11.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type
11.2.1 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2016-2021)
11.2.2 India RNA-based Biopharmaceuticals Sales Breakdown by Type (2022-2027)
11.3 India RNA-based Biopharmaceuticals Sales Breakdown by Application
11.3.1 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2016-2021)
11.3.2 India RNA-based Biopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in RNA-based Biopharmaceuticals Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Business Overview
12.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche RNA-based Biopharmaceuticals Products Offered
12.2.5 Roche Recent Development
12.3 Sanofi-Aventis
12.3.1 Sanofi-Aventis Corporation Information
12.3.2 Sanofi-Aventis Business Overview
12.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
12.3.5 Sanofi-Aventis Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Corporation Information
12.4.2 Abbott Laboratories Business Overview
12.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
12.4.5 Abbott Laboratories Recent Development
12.5 Arrowhead Pharmaceuticals
12.5.1 Arrowhead Pharmaceuticals Corporation Information
12.5.2 Arrowhead Pharmaceuticals Business Overview
12.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
12.5.5 Arrowhead Pharmaceuticals Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Corporation Information
12.6.2 Benitec Biopharma Business Overview
12.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
12.6.5 Benitec Biopharma Recent Development
12.7 Calimmune Inc
12.7.1 Calimmune Inc Corporation Information
12.7.2 Calimmune Inc Business Overview
12.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
12.7.5 Calimmune Inc Recent Development
12.8 Dicerna
12.8.1 Dicerna Corporation Information
12.8.2 Dicerna Business Overview
12.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
12.8.5 Dicerna Recent Development
12.9 Gradalis
12.9.1 Gradalis Corporation Information
12.9.2 Gradalis Business Overview
12.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
12.9.5 Gradalis Recent Development
12.10 Quark
12.10.1 Quark Corporation Information
12.10.2 Quark Business Overview
12.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Quark RNA-based Biopharmaceuticals Products Offered
12.10.5 Quark Recent Development
12.11 RXi
12.11.1 RXi Corporation Information
12.11.2 RXi Business Overview
12.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 RXi RNA-based Biopharmaceuticals Products Offered
12.11.5 RXi Recent Development
12.12 Senesco
12.12.1 Senesco Corporation Information
12.12.2 Senesco Business Overview
12.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Senesco RNA-based Biopharmaceuticals Products Offered
12.12.5 Senesco Recent Development
12.13 Silence Therapeutics
12.13.1 Silence Therapeutics Corporation Information
12.13.2 Silence Therapeutics Business Overview
12.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Products Offered
12.13.5 Silence Therapeutics Recent Development
12.14 Silenseed
12.14.1 Silenseed Corporation Information
12.14.2 Silenseed Business Overview
12.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Silenseed RNA-based Biopharmaceuticals Products Offered
12.14.5 Silenseed Recent Development
12.15 Tekmira
12.15.1 Tekmira Corporation Information
12.15.2 Tekmira Business Overview
12.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Tekmira RNA-based Biopharmaceuticals Products Offered
12.15.5 Tekmira Recent Development
12.16 Alnylam Pharmaceuticals
12.16.1 Alnylam Pharmaceuticals Corporation Information
12.16.2 Alnylam Pharmaceuticals Business Overview
12.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
12.16.5 Alnylam Pharmaceuticals Recent Development

13 RNA-based Biopharmaceuticals Manufacturing Cost Analysis
13.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
13.4 RNA-based Biopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 RNA-based Biopharmaceuticals Distributors List
14.3 RNA-based Biopharmaceuticals Customers

15 Market Dynamics
15.1 RNA-based Biopharmaceuticals Market Trends
15.2 RNA-based Biopharmaceuticals Drivers
15.3 RNA-based Biopharmaceuticals Market Challenges
15.4 RNA-based Biopharmaceuticals Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global RNA-based Biopharmaceuticals Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global RNA-based Biopharmaceuticals Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global RNA-based Biopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global RNA-based Biopharmaceuticals Sales (K Units) by Region (2016-2021)
Table 5. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2016-2021)
Table 6. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global RNA-based Biopharmaceuticals Revenue Share by Region (2016-2021)
Table 8. Global RNA-based Biopharmaceuticals Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 10. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global RNA-based Biopharmaceuticals Revenue Share Forecast by Region (2022-2027)
Table 12. Global RNA-based Biopharmaceuticals Sales (K Units) of Key Companies (2016-2021)
Table 13. Global RNA-based Biopharmaceuticals Sales Share by Company (2016-2021)
Table 14. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 15. Global RNA-based Biopharmaceuticals Revenue Share by Company (2016-2021)
Table 16. Global RNA-based Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-based Biopharmaceuticals as of 2020)
Table 17. Global RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global RNA-based Biopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 22. Global RNA-based Biopharmaceuticals Sales Share by Type (2016-2021)
Table 23. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 25. Global RNA-based Biopharmaceuticals Sales Share by Type (2022-2027)
Table 26. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global RNA-based Biopharmaceuticals Revenue Share by Type (2022-2027)
Table 28. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2022-2027)
Table 29. Global RNA-based Biopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 30. Global RNA-based Biopharmaceuticals Sales Share by Application (2016-2021)
Table 31. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2016-2021)
Table 33. Global RNA-based Biopharmaceuticals Sales (K Units) by Application (2022-2027)
Table 34. Global RNA-based Biopharmaceuticals Sales Share by Application (2022-2027)
Table 35. Global RNA-based Biopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global RNA-based Biopharmaceuticals Revenue Share by Application (2022-2027)
Table 37. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2022-2027)
Table 38. North America RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 39. North America RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 40. North America RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 42. North America RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 43. North America RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 44. North America RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 45. North America RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 46. North America RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 47. North America RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 48. North America RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 49. North America RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 50. Europe RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 51. Europe RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 52. Europe RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 54. Europe RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 55. Europe RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 56. Europe RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 57. Europe RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 58. Europe RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 59. Europe RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Europe RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 61. Europe RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 62. China RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 63. China RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 64. China RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 65. China RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 66. China RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 67. China RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 68. China RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 69. China RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 70. China RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 71. China RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 72. China RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 73. China RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 74. Japan RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 75. Japan RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 76. Japan RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 78. Japan RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 79. Japan RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 80. Japan RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 81. Japan RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 82. Japan RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 83. Japan RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 84. Japan RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 85. Japan RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 98. India RNA-based Biopharmaceuticals Sales (K Units) by Company (2016-2021)
Table 99. India RNA-based Biopharmaceuticals Sales Market Share by Company (2016-2021)
Table 100. India RNA-based Biopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 101. India RNA-based Biopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 102. India RNA-based Biopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 103. India RNA-based Biopharmaceuticals Sales Market Share by Type (2016-2021)
Table 104. India RNA-based Biopharmaceuticals Sales by Type (2022-2027) & (K Units)
Table 105. India RNA-based Biopharmaceuticals Sales Market Share by Type (2022-2027)
Table 106. India RNA-based Biopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 107. India RNA-based Biopharmaceuticals Sales Market Share by Application (2016-2021)
Table 108. India RNA-based Biopharmaceuticals Sales by Application (2022-2027) & (K Units)
Table 109. India RNA-based Biopharmaceuticals Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer RNA-based Biopharmaceuticals Product
Table 114. Pfizer Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Roche RNA-based Biopharmaceuticals Product
Table 119. Roche Recent Development
Table 120. Sanofi-Aventis Corporation Information
Table 121. Sanofi-Aventis Description and Business Overview
Table 122. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi-Aventis RNA-based Biopharmaceuticals Product
Table 124. Sanofi-Aventis Recent Development
Table 125. Abbott Laboratories Corporation Information
Table 126. Abbott Laboratories Description and Business Overview
Table 127. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Abbott Laboratories RNA-based Biopharmaceuticals Product
Table 129. Abbott Laboratories Recent Development
Table 130. Arrowhead Pharmaceuticals Corporation Information
Table 131. Arrowhead Pharmaceuticals Description and Business Overview
Table 132. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 134. Arrowhead Pharmaceuticals Recent Development
Table 135. Benitec Biopharma Corporation Information
Table 136. Benitec Biopharma Description and Business Overview
Table 137. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Benitec Biopharma RNA-based Biopharmaceuticals Product
Table 139. Benitec Biopharma Recent Development
Table 140. Calimmune Inc Corporation Information
Table 141. Calimmune Inc Description and Business Overview
Table 142. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Calimmune Inc RNA-based Biopharmaceuticals Product
Table 144. Calimmune Inc Recent Development
Table 145. Dicerna Corporation Information
Table 146. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Dicerna Description and Business Overview
Table 148. Dicerna RNA-based Biopharmaceuticals Product
Table 149. Dicerna Recent Development
Table 150. Gradalis Corporation Information
Table 151. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Gradalis Description and Business Overview
Table 153. Gradalis RNA-based Biopharmaceuticals Product
Table 154. Gradalis Recent Development
Table 155. Quark Corporation Information
Table 156. Quark Description and Business Overview
Table 157. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Quark RNA-based Biopharmaceuticals Product
Table 159. Quark Recent Development
Table 160. RXi Corporation Information
Table 161. RXi Description and Business Overview
Table 162. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. RXi RNA-based Biopharmaceuticals Product
Table 164. RXi Recent Development
Table 165. Senesco Corporation Information
Table 166. Senesco Description and Business Overview
Table 167. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Senesco RNA-based Biopharmaceuticals Product
Table 169. Senesco Recent Development
Table 170. Silence Therapeutics Corporation Information
Table 171. Silence Therapeutics Description and Business Overview
Table 172. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Silence Therapeutics RNA-based Biopharmaceuticals Product
Table 174. Silence Therapeutics Recent Development
Table 175. Silenseed Corporation Information
Table 176. Silenseed Description and Business Overview
Table 177. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Silenseed RNA-based Biopharmaceuticals Product
Table 179. Silenseed Recent Development
Table 180. Tekmira Corporation Information
Table 181. Tekmira Description and Business Overview
Table 182. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Tekmira RNA-based Biopharmaceuticals Product
Table 184. Tekmira Recent Development
Table 185. Alnylam Pharmaceuticals Corporation Information
Table 186. Alnylam Pharmaceuticals Description and Business Overview
Table 187. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 189. Alnylam Pharmaceuticals Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. RNA-based Biopharmaceuticals Distributors List
Table 193. RNA-based Biopharmaceuticals Customers List
Table 194. RNA-based Biopharmaceuticals Market Trends
Table 195. RNA-based Biopharmaceuticals Market Drivers
Table 196. RNA-based Biopharmaceuticals Market Challenges
Table 197. RNA-based Biopharmaceuticals Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA-based Biopharmaceuticals Product Picture
Figure 2. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. Therapeutics Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 6. Cancer Examples
Figure 7. Diabetes Examples
Figure 8. Tuberculosis Examples
Figure 9. Cardiovascular Diseases Examples
Figure 10. Others Examples
Figure 11. Global RNA-based Biopharmaceuticals Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global RNA-based Biopharmaceuticals Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global RNA-based Biopharmaceuticals Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global RNA-based Biopharmaceuticals Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global RNA-based Biopharmaceuticals Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global RNA-based Biopharmaceuticals Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America RNA-based Biopharmaceuticals Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe RNA-based Biopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China RNA-based Biopharmaceuticals Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan RNA-based Biopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia RNA-based Biopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India RNA-based Biopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India RNA-based Biopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue in RNA-based Biopharmaceuticals: 2016 & 2020
Figure 30. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global RNA-based Biopharmaceuticals Revenue Share by Type (2016-2021)
Figure 32. Global RNA-based Biopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global RNA-based Biopharmaceuticals Revenue Share by Application (2016-2021)
Figure 34. Global RNA-based Biopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 36. North America RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 37. Europe RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 38. Europe RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 39. China RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 40. China RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 41. Japan RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 42. Japan RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 43. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 44. Southeast Asia RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 45. India RNA-based Biopharmaceuticals Sales Market Share by Type in 2020
Figure 46. India RNA-based Biopharmaceuticals Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of RNA-based Biopharmaceuticals
Figure 49. Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure 50. RNA-based Biopharmaceuticals Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed